000 | 01201 a2200337 4500 | ||
---|---|---|---|
005 | 20250512063000.0 | ||
264 | 0 | _c19871021 | |
008 | 198710s 0 0 eng d | ||
022 | _a0732-6580 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHaranaka, K | |
245 | 0 | 0 |
_aAntitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy. _h[electronic resource] |
260 |
_bJournal of biological response modifiers _cAug 1987 |
||
300 |
_a379-91 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aGlycoproteins _xtherapeutic use |
650 | 0 | 4 | _aHot Temperature |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aNeoplasms, Experimental _xtherapy |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
650 | 0 | 4 |
_aSarcoma, Experimental _xtherapy |
650 | 0 | 4 | _aTumor Necrosis Factor-alpha |
700 | 1 | _aSakurai, A | |
700 | 1 | _aSatomi, N | |
773 | 0 |
_tJournal of biological response modifiers _gvol. 6 _gno. 4 _gp. 379-91 |
|
999 |
_c3630939 _d3630939 |